EQ-5D作为临床结局评估工具的局限性。 - Suppr

Suppr

超能文献

The Limitations of EQ-5D as a Clinical Outcome Assessment Tool.

作者信息

Gnanasakthy Ari, DeMuro Carla Romano

机构信息

RTI Health Solutions, Patient-Centered Outcomes Research, Research Triangle Park, NC, USA.

出版信息

Patient. 2024 May;17(3):215-217. doi: 10.1007/s40271-024-00683-w. Epub 2024 Mar 11.

DOI:10.1007/s40271-024-00683-w

PMID:38466537

Abstract

摘要

相似文献

The Limitations of EQ-5D as a Clinical Outcome Assessment Tool.EQ-5D作为临床结局评估工具的局限性。

Patient. 2024 May;17(3):215-217. doi: 10.1007/s40271-024-00683-w. Epub 2024 Mar 11.

Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.比较EQ-5D-5L在不同给药方式下的测量等效性。

Health Qual Life Outcomes. 2015 Nov 26;13:191. doi: 10.1186/s12955-015-0382-6.

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.手部类风湿关节炎患者中SF-12、SF-6D、EQ-5D及密歇根手部结果问卷的实证评估

Health Qual Life Outcomes. 2017 Jan 24;15(1):20. doi: 10.1186/s12955-016-0584-6.

The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression.青少年持续性重度抑郁症患者健康相关生活质量的 EQ-5D 测量的有效性和反应度。

J Ment Health. 2013 Apr;22(2):101-10. doi: 10.3109/09638237.2013.779366.

Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.肺癌健康状态的社会偏好（效用）分类与比较：癌症护理结果研究与监测（CanCORS）研究的结果

Med Decis Making. 2015 Apr;35(3):371-87. doi: 10.1177/0272989X15570364. Epub 2015 Feb 10.

The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.疾病严重程度对慢性心力衰竭 EQ-5D 和 SF-6D 效用差异的影响。

Eur J Health Econ. 2011 Aug;12(4):383-91. doi: 10.1007/s10198-010-0252-4. Epub 2010 May 15.

The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.在测量等待全髋关节置换术或全膝关节置换术的患者的健康相关生活质量方面，EQ-5D-5L 优于 -3L 版本。

Clin Orthop Relat Res. 2019 Jul;477(7):1632-1644. doi: 10.1097/CORR.0000000000000662.

Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.EQ-5D 在评估首发精神病青年患者健康相关生活质量中的作用。

Qual Life Res. 2013 Jun;22(5):1055-63. doi: 10.1007/s11136-012-0222-7. Epub 2012 Jun 17.

EQ-5D Brazilian population norms.EQ-5D巴西人群常模。

Health Qual Life Outcomes. 2021 Jun 10;19(1):162. doi: 10.1186/s12955-021-01671-6.

Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.EQ-5D-5L 健康相关生活质量问卷在自我报告糖尿病中的有效性：来自一般人群调查的证据。

Health Qual Life Outcomes. 2021 May 5;19(1):138. doi: 10.1186/s12955-021-01780-2.

引用本文的文献

From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018-2022).从临床试验到为临床决策提供信息：欧洲药品管理局批准的非肿瘤药物患者报告结局综述（2018 - 2022年）

Front Pharmacol. 2025 Apr 11;16:1536401. doi: 10.3389/fphar.2025.1536401. eCollection 2025.

Measuring the quality of life of patients with diabetic retinopathy in northern India: a comparison of generic and vision specific instruments.评估印度北部糖尿病视网膜病变患者的生活质量：通用型与视力特异性工具的比较

Health Qual Life Outcomes. 2025 Feb 21;23(1):17. doi: 10.1186/s12955-025-02340-8.

Determinants of poor health-related quality of life among outpatients with rheumatoid arthritis in Jordan.约旦门诊类风湿关节炎患者健康相关生活质量差的决定因素。

PLoS One. 2024 Oct 23;19(10):e0312557. doi: 10.1371/journal.pone.0312557. eCollection 2024.

Estimating an EQ-5D-Y-3L Value Set for Brazil.估算巴西的 EQ-5D-Y-3L 值集。

Pharmacoeconomics. 2024 Sep;42(9):1047-1063. doi: 10.1007/s40273-024-01404-9. Epub 2024 Jul 2.

本文引用的文献

A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021).基于欧洲药品管理局（2017-2021 年）批准的新型肿瘤药物的患者报告结局终点的标签评价综述。

Value Health. 2023 Jun;26(6):893-901. doi: 10.1016/j.jval.2023.01.017. Epub 2023 Feb 4.

Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).曲妥珠单抗和卡培他滨联合治疗人表皮生长因子受体 2 阳性转移性乳腺癌患者中添加图卡替尼或安慰剂对生活质量的影响（HER2CLIMB 试验）。

Eur J Cancer. 2021 Aug;153:223-233. doi: 10.1016/j.ejca.2021.05.025. Epub 2021 Jun 29.

How Do Respondents Interpret and View the EQ-VAS? A Qualitative Study of Three Asian Populations.受访者如何理解和看待 EQ-VAS？对三个亚洲人群的定性研究。

Patient. 2021 Mar;14(2):283-293. doi: 10.1007/s40271-020-00452-5.

Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.哪些多属性效用仪器推荐用于成本效用分析？国家卫生技术评估（HTA）指南的回顾。

Eur J Health Econ. 2020 Nov;21(8):1245-1257. doi: 10.1007/s10198-020-01195-8. Epub 2020 Jun 8.

EQ-5D and the EuroQol Group: Past, Present and Future.EQ-5D与欧洲生活质量小组：过去、现在与未来。

Appl Health Econ Health Policy. 2017 Apr;15(2):127-137. doi: 10.1007/s40258-017-0310-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验